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A B S T R A C T
Background Maternal early pregnancy overweight (body mass index [BMI] 25.0–29.9 kg/m2) and obesity
(BMI≥ 30 kg/m2) are associated with mental and physical health adversities in the offspring. Prenatal pro-
gramming of the hypothalamic-pituitary-adrenal (HPA) axis has been put forward as one of the mechanisms that
may play pathophysiological role. However, evidence linking maternal overweight and obesity with offspring
HPA-axis activity is scarce. We studied if maternal early pregnancy BMI is associated with diurnal salivary
cortisol, a marker of HPA-axis activity, in young adult offspring.
Methods At a mean age of 25.3 (standard deviation [SD)=0.6) years, 653 Arvo Ylppö Longitudinal Study
participants collected saliva samples for cortisol analyses, at awakening, 15 and 30min thereafter, 10:30AM,
12:00PM, 5:30PM and at bedtime. Maternal BMI was calculated from weight and height verified by a mea-
surement in the first antenatal clinic visit before 12 weeks of gestation derived from healthcare records.
Results Per each one kg/m2 higher maternal early pregnancy BMI offspring diurnal average salivary cortisol
was -1.4% (95% CI:-2.6, -0.2, pFDR=0.033) lower, at awakening it was -2.4% (95% CI:-4.0, -0.7, pFDR=0.025)
lower and the morning average salivary cortisol was -2.0% (95% CI:-3.4, -0.5, pFDR=0.017) lower. These as-
sociations were independent of the offspring’s own young adulthood BMI, and other important covariates.
Conclusion Our findings show that young adult offspring born to mothers with higher early pregnancy BMI
show lower average levels of diurnal cortisol, especially in the morning. Whether these findings reflect prenatal
programming of the offspring HPA-axis activity warrants further investigation.
1. Introduction
In 2014, 14.9% of adult women worldwide were obese (body mass
index [BMI]≥30 kg/m2) (NCD-RisC, 2016) with the global prevalence
of obesity in women expected to increase to 21% by 2025 (NCD-RisC,
2016). Consequently, the prevalence of obesity in pregnant women has
been increasing varying from 7 to 21% across European Union coun-
tries (Devlieger et al., 2016; Euro-Peristat, 2013) and 18 to 31% across
the United States (Branum et al., 2016; Deputy et al., 2018). The
number of pregnant women who are overweight (BMI 25–29.99 kg/m2)
is high as well:17-28% in European union countries (Euro-Peristat,
2013) and 23–28% in the United States (Deputy et al., 2018). Over-
weight and obesity in pregnancy pose multiple health risks for the
mother, increasing risk for gestational diabetes (Torloni et al., 2009),
hypertensive pregnancy disorders (Gaillard et al., 2011; Wang et al.,
2013), pregnancy and postpartum depression (Kumpulainen et al.,
2018; Molyneaux et al., 2014), and longer hospital stays after delivery
(Chu et al., 2008). Maternal overweight and obesity also increase the
risk of caesarean section delivery (Poobalan et al., 2009) and adverse
neonatal outcome, including preterm birth (McDonald et al., 2010),
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large-for-gestational-age birth weight and macrosomia (Ehrenberg
et al., 2004), birth injury, asphyxia and respiratory problems, convul-
sions, hypoglycaemia (Blomberg, 2013) and congenital malformations
(Persson et al., 2017). Maternal overweight and obesity are also major
risk factors for stillbirth (Flenady et al., 2011).
The adverse consequences of maternal overweight and obesity on
the offspring not only pertain to the neonatal and infancy periods, but
emerging evidence suggests that they may persist into later life stages.
In follow-up studies, the adverse outcomes associated with maternal
early pregnancy overweight and obesity include increased risk of
asthma and wheezing in children (Forno et al., 2014), poorer cardio-
metabolic profile (higher BMI, fat mass, blood pressure, lipids, in-
flammation) in children and adults (Eriksson et al., 2015; Godfrey et al.,
2017; Kaseva et al., 2018), higher risk of neurodevelopmental delay
(Girchenko et al., 2018) and poorer neurocognitive functioning in
children (Álvarez-Bueno et al., 2017; Contu and Hawkes, 2017; Huang
et al., 2014), and higher risk of any mental and psychological devel-
opment (Kong et al., 2018; Rivera et al., 2015), attention deficit hy-
peractivity (Gardner et al., 2015; Kong et al., 2018; Rodriguez, 2010;
Rodriguez et al., 2008), conduct (Kong et al., 2018), mood (Kong et al.,
2018; Van Lieshout et al., 2013), anxiety (Rivera et al., 2015), and
autism spectrum disorders (Gardner et al., 2015; Kong et al., 2018;
Xiang et al., 2015) in children, psychosis in children (Kong et al., 2018)
and schizophrenia in adults (Khandaker et al., 2012). The adverse adult
outcomes additionally include increased risk for diabetes (Eriksson
et al., 2014; Godfrey et al., 2017), cardiovascular disease morbidity and
mortality (Eriksson et al., 2014; Reynolds et al., 2013) and all-cause
mortality (Reynolds et al., 2013).
These findings are compatible with the Developmental Origins of
Health and Disease (DOHaD) framework, which suggests that exposure
to environmental adversity in the prenatal life may program organs and
their functioning in ways that increase risk for physical and mental
disorders later in life (Barker, 2004). Programming of the hypotha-
lamic-pituitary-adrenal (HPA) axis has been put forward as one of the
mechanisms that may play pathophysiological role (Duthie and
Reynolds, 2013; Räikkönen et al., 2010; Seckl and Meaney, 2004).
Yet, to the best of our knowledge only a handful of studies have
focused upon the associations between maternal overweight and obe-
sity during pregnancy and offspring HPA axis activity in humans. In one
of these studies severe maternal obesity (BMI≥ 40 kg/m2) measured in
early pregnancy was associated with higher salivary cortisol reactivity
in response to a delayed gratification test in the 3-5-year-old offspring
(Mina et al., 2017). In one other study maternal pre-pregnancy BMI,
calculated from retrospectively reported weight after pregnancy and
measured height, was not associated with the 4-5-year-old offspring
salivary cortisol morning peak or diurnal decline sampled across three
points: upon arrival at preschool in the morning, before lunch and in
the afternoon upon arrival back to the child’s home. This same study
also reported that maternal early pregnancy BMI was not associated
with salivary cortisol reactivity in response to four challenge tasks
(drawing a ‘perfect’ circle, solving a puzzle, waiting as the examiner
wrapped up a favourite prize the child had previously chosen, getting
the least favoured prize instead of the most favoured one) (Elhassan
et al., 2015). Maternal early pregnancy BMI, derived from medical re-
cords, was not associated with cortisol measured from a morning
plasma sample in the 8.5-year old offspring (Phillips et al., 2005). A
recent study also showed that maternal severe obesity in early preg-
nancy, derived from medical records, was not associated with cortisol,
corticosterone or 11-dehydrocorticosterone measured from fetal cord
blood plasma collected at delivery (Stirrat et al., 2017).
Differences in the study set ups in these previous studies (e.g.,
cortisol measured from saliva, peripheral blood or cord blood plasma;
number of samples taken; variation in time point(s) of measurement
and types of stressors employed) may possibly explain the mixed
findings. Further, the sample sizes have been relatively small and follow
ups have been limited to childhood. As the HPA-axis may undergo age-
related changes (Gunnar et al., 2014; Lupien et al., 2009), it is im-
portant to know if maternal overweight and obesity are associated with
offspring HPA-axis activity when measured in adulthood.
Thus, we tested if maternal early pregnancy BMI was associated
with diurnal salivary cortisol in a large sample of their offspring fol-
lowed up from birth to the mean age of 25.3 years. As maternal early
pregnancy overweight and obesity have been shown to be associated
with higher BMI and fat mass in the offspring throughout childhood to
adulthood (Eriksson et al., 2015; Godfrey et al., 2017; Kaseva et al.,
2018), as higher BMI in a general population (Adam et al., 2017) and in
pregnant women is associated with lower HPA-axis activity (Aubuchon-
Endsley et al., 2014; Berglund et al., 2016; Luiza et al., 2015; Stirrat
et al., 2016), and as maternal and fetal cortisol levels are correlated
(Gitau et al., 2001; Stirrat et al., 2017), we hypothesized that higher
maternal early pregnancy BMI would be associated with lower diurnal
salivary cortisol of the offspring in adulthood. Further, as also lower
levels of BMI have been shown to be associated with lower HPA axis
activity in a general population (Kumari et al., 2010), we tested if the
associations between maternal early pregnancy BMI and offspring
diurnal salivary cortisol were non-linear.
2. Methods
2.1. Participants
Participants come from the Arvo Ylppö Longitudinal Study (AYLS)
(Heinonen et al., 2008; Riegel et al., 1995; Wolke et al., 1998) They
were recruited from a total of 15,311 deliveries in the seven maternity
hospitals in the county of Uusimaa, Finland between March 15, 1985
and March 14, 1986. The sample comprised 2193 infants (1193 boys).
Of them 1535 (867 boys; 70% of the total sample of 2193) were ad-
mitted to the neonatal wards of the obstetric units, or to the Neonatal
Intensive Care Unit (NICU) of the Children’s Hospital within ten days
after birth. The neonates ranged from severely ill preterm infants to
infants requiring only brief inpatient observation. The majority of the
admitted infants had no diagnosed illness and were on the ward for
observation or because of common problems relating to neonatal
adaptation (Heinonen et al., 2008). An additional 658 (326 boys; 30%
of the total sample of 2193) infants, not admitted to neonatal wards,
were prospectively recruited from births occurring after every second
hospitalized infant in the three largest maternity hospitals in the study
area during the same period. Details of the study cohort are presented
elsewhere (Heinonen et al., 2008; Riegel et al., 1995).
In 2009–2012 the still traceable 1913 (87.2%) participants of the
original cohort were invited for a clinical and psychological follow-up
(for 107 personal identification number was not available, for 173
participants of the original cohort, addresses were not traceable, they
were living abroad or would have needed accommodation for an
overnight stay). Of the traceable participants, 1136 participated
(59.4%; 51.8% of the original cohort) in the young adulthood follow-
up, and of them, 848 participants (74.6%; 38.7% of the original cohort)
provided salivary samples for cortisol measurements during one day.
We excluded young adult participants with congenital malforma-
tions or chromosomal abnormalities (n= 6), shift workers (n=3),
those who were pregnant (n= 2), and those who did not provide valid
salivary cortisol samples (n= 53; 11 had ≥2 missing saliva samples
out of seven samples, 38 had taken≥2 saliva samples on different days,
3 had one missing sample and ≥1 sample(s) taken on different days,
and 1 had all seven cortisol values were above the upper limit of assay
range (> 100 nmol/L). We additionally excluded participants using
inhaled (n= 15) or oral (n= 16) glucocorticoids and nasal corticos-
teroids (n= 6) because of their effects on cortisol levels. This left us
with 747 participants with at least 6 salivary samples; of them data on
maternal BMI in early pregnancy were available for 653 participants
(327 men; 29.8% of the original cohort). They formed the analytic
sample of our study, who at the follow-up were on average 25.3
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(SD=0.6, Range=24.4–27.1) years of age. Fig. 1 shows a flow chart
of the sample and attrition.
Compared to those participants who were invited but did not par-
ticipate in the follow-up at a mean age of 25.3-years or who were ex-
cluded from the analysis (n= 1260), those who participated in the
adulthood follow-up and were included in the analytic sample
(n=653) were less often hospitalized at birth (60.6% vs 72.8%;
p < 0.0001), were born to older mothers (29.9 vs 29.2 years;
p=0.001), had parents with higher education (upper tertiary 34.2% vs
22.1%; p<0.0001), had higher weight (3394 vs 3242 g; p < 0.0001)
and gestational age at birth (39.1 vs 38.6 weeks; p < 0.0001), and
were more often women (49.9% vs 43.5%: p=0.007).
The childhood study protocol was approved by ethics committees of
the Helsinki City Maternity Hospital, the Helsinki University Central
Hospital, and the Jorvi Hospital and in adulthood by the Coordinating
Ethics Committee of the Helsinki and Uusimaa Hospital District.
Informed consent was obtained from the mother when the participants
were in childhood. In adulthood written informed consent was obtained
from the participating offspring.
2.2. Measures
2.2.1. Maternal early pregnancy BMI
Maternal early pregnancy BMI (kg/m2), which was calculated from
weight and height verified by a nurse at the first visit to the antenatal
clinic before 12 weeks of gestation, was extracted from healthcare re-
cords. We used BMI as a continuous variable in our analyses. For dis-
play purposes we also categorized BMI into pooled underweight
(< 18.50 kg/m2, n= 47) and normal weight (18.5–24.99 kg/m2,
n=515) and pooled overweight (25–29.99 kg/m2, n=76) and obese
(≥30 kg/m2, n= 15) groups, as offspring cortisol concentrations of
mothers with early pregnancy underweight and normal weight did not
differ (p-values>0.16) and as the number of mothers with obesity was
small in our sample.
2.2.2. Offspring diurnal salivary cortisol at a mean age of 25.3 years
Participants collected seven saliva samples during a one-day period:
upon awakening (cortisol available for 653 participants; Mean
(M)=7:25AM hh:mm, SD=1:17 hh:mm), 15min (n= 651;
M=7:41AM, SD=1:17) and 30min (n= 650; M=7:57AM,
SD=1:17) thereafter, at 10:30AM (n=645; M=10:35AM,
SD=0:29), at noon (n= 649; M=12:13, SD=0:43), at 5:30PM
(n= 642; M=5:43PM, SD=0:39) and at bedtime (n= 638;
M=11:42PM, SD=1:23). Participants were instructed to avoid
brushing their teeth and eating within 30min after awakening. They
were also asked to record the date and time at sample collection. We
allowed one missing salivary cortisol sample for analysis; of the parti-
cipants with at least 6 salivary cortisol samples (n=653), 66 (10.1%)
had at least one missing time value of sampling. Missing sampling times
were manually imputed using the pre-determined times of the salivary
sampling protocol (e.g., if sampling time of the second salivary sample
was missing, but awakening time was recorded, awakening time+15
min was imputed) or study population mean of the sampling time.
Altogether 393 (8.7%) missing salivary sampling times out of 4528
were imputed.
2.2.2.1. Biochemical analyses. Samples were collected between
November 2009 and May 2012. Samples were stored at −20 °C and
analyzed in May-June 2012 at University of Trier, Germany. Salivary
cortisol concentrations were determined by use of a competitive, solid-
phase, time-resolved fluorescence immunoassay with fluorometric end
point detection (DELFIA; Wallac, Turku, Finland) (Dressendorfer et al.,
1992).
Cortisol concentrations were measured in duplicate and averaged. If
the second measure was not available, the single concentration mea-
sured was used.
The inter-assay coefficients of variation of the control samples were
6.53% for a mean concentration of 3.70 nmol/L, 7.69% for 7.73 nmol/L
and 6.88% for 18.38 nmol/L. The intra-assay coefficients of variation
ranged between 4.0 and 6.7%.
2.2.2.2. Cortisol parameters. Cortisol values above the upper limit of
assay range (> 100 nmol/L) were truncated at 100 (n= 1 at
awakening, n= 3 at 15 and 30min after awakening, n=2 at
10:30AM, n= 1 at 12:00PM; n=2 at 5:30PM; and n=4 at
bedtime). As cortisol concentrations in samples from awakening to
n=195 (8.9% of the original 
cohort ) excluded; they 
comprise: n=6 congenital 
malformations, chromosomal 
abnormalities, n=3 shift 
workers, n=2 pregnant 
women, n=53 without valid 
cortisol samples, n=37 using 
nasal/inhaled/oral 
glucocorticoid medications , 
n=94 without data on 
maternal early pregnancy 
body mass index
Analytic sample 
n= 653 (29.8% of the original cohort) with data on 
maternal early pregnancy body mass index and diurnal salivary cortisol 
Follow-up 2009-2012
at a mean age of 25.3 years
n=1136 (51.8% or the original cohort) participated
n=848 (38.7% of the original cohort) with data on 
diurnal salivary cortisol
N=2193 original cohort
infants born between between March 15, 1985 and March 14, 1986 in 
the seven maternity hospitals in the county of Uusimaa, Finland (1,535 
hospitalized and 658 not hospitalized within 10 days after birth)
n=107 no personal 
identification number, n=173 
could not be traced/would 
have needed 
accommodation for overnight 
stay  (12.8%)
n=288 (13.1 % of the original 
cohort) did not participate in 
salivary cortisol sampling 
n=1913 (87.2% of the original cohort) invited to 25-year follow-up n=777 (35.4% of original cohort) did not participate
Overall attrition 
rate 
1540/2193=70.2%
Fig. 1. Flowchart of the participants and sample attrition of the Arvo Ylppö Longitudinal Study.
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bedtime were skewed, we used natural logarithm to normalize their
distributions. To study the diurnal average salivary cortisol and the
degree of change in salivary cortisol from morning to bedtime (cortisol
slopes) we used all seven cortisol values (Hruschka et al., 2005). We
also studied average morning (first three samples) and mid-morning to
bedtime (samples from 10 AM to bedtime) salivary cortisol averages
and slopes. Furthermore, we studied separately salivary cortisol at
awakening and at bedtime, and calculated integrated cortisol measures,
namely time-weighted area under the curve with respect to ground
(AUCg) and time-weighted AUC with respect to increase/change
(AUCi) from the three raw morning values (Pruessner et al., 2003) to
study the average morning cortisol and cortisol awakening response,
respectively. Awakening, bedtime and AUCg and AUCi values were
normalized due to skewed distributions using natural logarithm.
2.3. Covariates
We used covariates that either theoretically or according to previous
literature are related to maternal overweight/obesity (Gaillard et al.,
2011; Torloni et al., 2009; Wang et al., 2013) and/or cortisol secretion
(Adam and Kumari, 2009; Kajantie and Räikkönen, 2010; Kudielka and
Kirschbaum, 2003; Roche et al., 2013). In Model 1, we adjusted for
salivary sampling times for the diurnal cortisol profile analyses, and
time of salivary sample at awakening for cortisol awakening, AUCg and
AUCi analyses, and at awakening and bedtime for cortisol bedtime
analyses, sex hormonal contraception use (women no contraception/
women yes contraception/men) and age (years) at salivary collection
day.
Model 2 included model 1 covariates plus offspring’s BMI (kg/m2)
measured at the follow-up at a mean age of 25.3 years. Model 3 in-
cluded model 2 covariates plus participant’s gestational age at birth
(weeks) (Kajantie and Räikkönen, 2010), birth weight standardized for
gestational age and sex SD score, maternal age at delivery (years),
maternal diabetes (type 1 diabetes, type 2 diabetes or gestational dia-
betes; yes vs no) and maternal hypertensive disorders (chronic hy-
pertension, gestational hypertension, pre-eclampsia, superimposed pre-
eclampsia; yes vs no), smoking during pregnancy (yes/no), parity
(primiparous vs multiparous) derived from hospital birth records and
highest parental education (primary/lower secondary or less, upper
secondary, lower tertiary, upper tertiary) reported by the mother in
childhood or reported by the offspring at the follow-up at a mean age of
25.3 years.
Model 4 included model 2 covariates plus offspring’s self-reported
alcohol consumption (no use or 3–4 times or less often per year, 1–2
times/month, weekly or daily; missing (n= 28) dummy coded as se-
parate category), smoking (yes, ex-smoker, no; missing (n=9) dummy
coded as separate category) and own completed/ongoing education
(primary/lower secondary or less, upper/studying for upper secondary,
lower tertiary/studying for lower tertiary, upper tertiary/studying for
upper tertiary; missing (n=15) dummy coded as separate category) at
the follow-up at a mean age of 25.3 years.
2.4. Statistical analyses
We studied if the offspring daily average and degree of change in the
diurnal cortisol from awakening to bedtime (cortisol slopes) varied
according to maternal early pregnancy BMI by using random coeffi-
cients mixed model regression. In these analyses the seven cortisol
values from awakening to bedtime were treated as outcome variables.
The models included maternal early pregnancy BMI as a between-
person predictor, salivary cortisol sampling time (transformed to SD
units, M=0, SD=1; to retain the within-time variation we used the
mean of the times across the 7 salivary cortisol samplings) as a time-
varying within-person predictor, and their interaction. Covariates were
included in the model as fixed effects. We specified an unstructured
(UN) covariance matrix and allowed random effects in the model to
account for individual differences in the intercept and in the slope.
We re-ran the mixed-model analyses to study if morning (upon
awakening and 15 and 30min thereafter) and mid-morning to bedtime
(10:30AM until bedtime) salivary cortisol averages and slopes varied
according to maternal early pregnancy BMI.
Further, by using generalized linear models (GLM) with Gaussian
reference distribution, we examined if maternal early pregnancy BMI
was associated with the offspring salivary cortisol at awakening and at
bedtime, and salivary cortisol AUCg and AUCi calculated from the three
morning values.
Finally, non-linearity of the associations was tested by adding ma-
ternal early pregnancy BMI x maternal early pregnancy BMI interaction
into the regression equation in the mixed model regressions and GLMs
following the main effect of maternal early pregnancy BMI, and ma-
ternal early pregnancy BMI x maternal early pregnancy BMI x cortisol
sampling time into the mixed model regressions following their two-
way interactions and main effects.
The associations are presented as unstandardized estimates and
unstandardized regression coefficients and 95% confidence intervals
(95% CIs). The estimates/coefficients reflect change in salivary cortisol
in % (units transformed using natural logarithm back-transformed
using (exp(estimate/coefficient)-1)*100) per each kg/m2 unit change in
maternal BMI. All associations were adjusted for all covariates in four
different models. To control for error rate related to multiple testing,
the false-discovery rate (pFDR) was applied setting the false discovery
rate across 3 tests (main effects of maternal early pregnancy BMI on
diurnal and morning and mid-morning to bedtime salivary cortisol
values; maternal early pregnancy BMI x sampling time interactions on
diurnal and morning and mid-morning to bedtime salivary cortisol
values) for diurnal cortisol mixed model analyses and across 4 tests
(salivary cortisol at awakening, at bedtime and AUCg and AUCi) for
analyses of cortisol parameters at alpha level 0.05. All analyses were
conducted using IBM SPSS 24 (IBM Corp., Armonk, N.Y., USA).
3. Results
Table 1 presents the characteristics of the study sample according to
maternal pooled underweight/normal weight and pooled overweight/
obesity groups. In comparison to mothers with underweight/normal
weight, mothers with overweight/obesity in early pregnancy were
older, more often had chronic or gestational hypertension and gesta-
tional diabetes and they themselves/their spouses less often had a
lower/upper tertiary education. Their offspring were born heavier and
had higher BMI at the 25.3-year follow-up.
3.1. Maternal early pregnancy BMI and offspring diurnal, morning and
mid-morning to bedtime salivary cortisol averages and slopes
Table 2 shows the findings of the mixed random coefficients re-
gression models. Higher maternal early pregnancy BMI was sig-
nificantly associated with lower diurnal salivary cortisol average of the
offspring (Table 2), but it was not significantly associated with the
diurnal cortisol slope from awakening to bedtime (p-values> 0.52 in
Models1–4 for maternal early pregnancy BMI x salivary cortisol sam-
pling time interaction; data not shown). When we tested the morning
and the mid-morning to bedtime averages and slopes, we found that
higher maternal early pregnancy BMI was significantly associated with
lower morning average cortisol of the offspring (Table 2), but it was not
associated with the morning cortisol slope (p-values> 0.37 in
Models1–4 for maternal early pregnancy BMI x salivary cortisol sam-
pling time interaction; data not shown) or with mid-morning to bedtime
cortisol average (Table 2) or slope (p-values> 0.44 in Models1–4 for
maternal early pregnancy BMI x salivary cortisol sampling time inter-
action; data not shown). The effect of maternal early pregnancy BMI on
diurnal and morning salivary cortisol averages remained significant
across adjustments for all covariates (models 1–4 in Table 2). The
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Table 1
Characteristics of the sample.
Maternal early pregnancy body mass index (N=653)
< 25.00 kg/m2 (N=562) ≥25.00 kg/m2 (N=91)
Mean (SD) /n (%) Mean (SD) /n (%) P for difference
Child characteristics
At birth
Sex (boys) 280 (49.8%) 47 (51.6%) 0.75
Gestational age (weeks) 39.1 (2.5) 39.2 (2.4) 0.72
Birth weight (grams) 3359 (697) 3610 (739) 0.002
Birth weight (standard deviation units by sex and gestational age) −0.1 (1.2) 0.4 (1.2) < 0.0001
Hospitalized within 10 days of birth 0.97
No 221 (39.3%) 36 (39.6%)
Yes 341 (60.7%) 55 (60.4%)
Multiple pregnancy 0.11
Singleton 535 (95.2%) 90 (98.9%)
Twin 27 (4.8%) 1 (1.1%)
At 25.3-year follow-up
Age 25.3 (0.6) 25.3 (0.6) 0.38
Cortisol (nmol/L), geometric means
At awakening 6.7 (2.1) 5.2 (2.1) 0.003
15minutes after awakening 8.9 (2.0) 6.89 (2.0) 0.001
30minutes after awakening 10.49 (1.9) 9.03 (1.8) 0.034
10:30AM 4.39 (2.1) 4.3 (1.9) 0.71
12:00PM 3.46 (2.1) 3.46 (2.0) 1.00
5:30PM 2.05 (2.2) 2.10 (2.5) 0.75
Bedtime 1.01 (2.8) 0.96 (3.4) 0.69
Cortisol parameters (nmol/L)
Awakening time-weighted area under the curve with respect to ground (AUCg) 339.0 (271.4) 268.6 (215.7) 0.019
Awakening time-weighted area under the curve with respect to increase/decrease (AUCi) 65.5 (160.7) 71.4 (174.6) 0.75
Salivary sample collection time points (hh:mm)
At awakening 7:27AM (1:16) 7:15AM (1:23) 0.17
15minutes after awakening 7:42AM (1:16) 7:30AM (1:23) 0.16
30minutes after awakening 7:58AM (1:16) 7:46AM (1:22) 0.18
10:30AM 10:35AM (0:30) 10:36AM (0:25) 0.85
12:00PM 12:13PM (0:44) 12:13PM (0.37) 0.91
5:30PM 5:42PM (0:39) 5:46PM (0:39) 0.43
Bedtime 11:42PM (1:25) 11:45PM (1:08) 0.72
Hormonal contraception (women) 0.34
No 111 (39.4%) 14 (31.8%)
Yes 171 (60.6%) 30 (68.2%)
Body mass index (kg/m2) 23.6 (4.1) 26.0 (4.7) < 0.0001
Level of education 0.06
Basic/primary or less 21 (3.8%) 5 (5.6%)
Upper secondary 166 (30.2%) 33 (37.1%)
Lower tertiary 138 (25.1%) 28 (31.5%)
Upper tertiary 224 (40.8%) 23 (25.8%)
Alcohol consumption 0.91
No 16 (3.0%) 4 (4.4%)
3-4 times/year or less often 27 (5.1%) 5 (5.5%)
1-2 times/month or couple of times/month 194 (36.3%) 32 (35.2%)
Weekly or daily 297 (55.6%) 50 (54.9%)
Cigarette smoking 0.78
Non-smoker 133 (24.1%) 21 (23.1%)
Ex-smoker 234 (42.3%) 36 (39.6%)
Smoker 186 (33.6%) 34 (37.4%)
Maternal characteristics
Body mass index (kg/m2) in early pregnancy 21.2 (1.9) 28.2 (3.4) < 0.0001
Age at delivery 29.7 (4.8) 31.4 (4.8) 0.001
Parity 0.93
Primiparous 293 (52.1%) 47 (51.6%)
Multiparous 269 (47.9%) 44 (48.4%)
Smoking during pregnancy 0.60
No 463 (82.4%) 77 (84.6%)
Yes 99 (17.6%) 14 (12.4%)
Diabetic disorders (type 1 and 2 diabetes, gestational diabetes) < 0.0001
No 530 (94.3%) 78 (85.7%)
Type 1 diabetes 13 (2.3%) 1 (1.1%)
Type 2 diabetes 0 (0.0%) 1 (1.1%)
Gestational diabetes mellitus 19 (3.4%) 11 (12.1%)
Hypertensive disorders < 0.0001
Normotensive 471 (83.8%) 60 (65.9%)
Chronic hypertension 21 (3.7%) 12 (13.2%)
Gestational hypertension 45 (8.0%) 17 (18.7%)
Pre-eclampsia, superimposed pre-eclampsia 25 (4.4%) 2 (2.2%)
Highest education of either parent 0.001
Basic/primary or less 44 (7.8%) 13 (14.3%)
(continued on next page)
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associations with diurnal (pFDR=0.033) and morning salivary cortisol
averages (pFDR=0.017) remained significant after correction for mul-
tiple testing. Fig. 2 illustrates these associations.
We also found significant non-linear U-shaped associations between
maternal early pregnancy BMI with diurnal salivary cortisol average
(p=0.020-0.026 for maternal early pregnancy BMI x maternal early
pregnancy BMI interaction in models 1–4, data not shown) and mid-
morning to bedtime salivary cortisol average (p=0.042-0.06 for ma-
ternal early pregnancy BMI x maternal early pregnancy BMI interac-
tion). These associations did not, however, survive the correction for
multiple testing (pFDR< 0.017 for diurnal salivary cortisol average,
pFDR< 0.033 for mid-morning to bedtime salivary cortisol average).
To exclude any potential bias that may have resulted from im-
putation of the 393 missing salivary cortisol sampling time points on
the findings, we re-ran the analyses by excluding the imputed ob-
servations from the analyses; it had no effect on the morning average
salivary cortisol (p=0.014); however the association between maternal
early pregnancy BMI and diurnal average salivary cortisol was atte-
nuated non-significant (p=0.06). We also re-ran the analyses by ex-
cluding the salivary cortisol values that were above the upper limit of
assay range (> 100 nmol/L) and which we truncated to 100 nmol/L); it
had no effect on the significant findings (p-values< 0.031).
3.2. Maternal early pregnancy BMI and offspring salivary cortisol upon
awakening, at bedtime and morning AUCg and AUCi
Table 3 shows the findings from the GLMs. Across all adjustment
models (models 1–4) and after correction for multiple testing higher
maternal early pregnancy BMI was associated with lower salivary cor-
tisol upon awakening (pFDR=0.025) and lower morning salivary cor-
tisol AUCg of the offspring (pFDR=0.013). It was not significantly as-
sociated with morning salivary cortisol AUCi or salivary cortisol at
bedtime. None of these associations were non-linear (p-values> 0.20
for maternal early pregnancy BMI x maternal early pregnancy BMI in-
teraction in models 1–4; data not shown).
4. Discussion
To our knowledge, this is the first study examining associations
between maternal BMI measured in early pregnancy before the 12th
gestational week and offspring diurnal salivary cortisol in young
adulthood. This study showed that higher maternal early pregnancy
BMI was linearly associated with lower diurnal salivary cortisol levels.
More specifically, per each one kg/m2 unit increase in maternal early
pregnancy BMI offspring average salivary cortisol levels during the day
were over -1% lower, and at awakening and on average in the morning
they were over -2% lower. While these findings are small in effect size,
the differences in the diurnal average, awakening and morning average
salivary cortisol levels were over -31% lower between those exposed to
the highest and the lowest maternal BMI in our cohort. Maternal early
pregnancy BMI was not significantly associated with the degree of
change in the diurnal salivary cortisol or morning salivary cortisol,
namely diurnal cortisol slope or with cortisol awakening response. It
was not either associated with mid-morning to bedtime salivary cortisol
average or slope. These associations were independent of the partici-
pant’s own young adulthood BMI and also remained significant after
adjustment for other important covariates related to both the mother
and the adult offspring, including maternal diabetic and hypertensive
pre-pregnancy and pregnancy disorders, parental education, offspring
gestational age, birth weight and attained/ongoing own young adult-
hood education. The associations were not either explained by nasal/
inhaled/oral glucocorticoid medications as their users were excluded
from this study sample, and were not accounted for the error rate re-
lated to multiple testing. We also tested if any of these associations were
non-linear, but none of the non-linear associations survived correction
for the error rate related to multiple testing.
The handful of studies that we are aware of that have tested asso-
ciations between maternal early pregnancy BMI and offspring HPA axis
activity have shown that higher maternal early pregnancy BMI is as-
sociated with either higher salivary cortisol in the pre-school-aged
offspring in response to a delayed-gratification test (Mina et al., 2017),
or have shown that it is not associated with the pre-school aged off-
spring diurnal or stress-induced salivary cortisol, school-aged offspring
Table 1 (continued)
Maternal early pregnancy body mass index (N=653)
Upper secondary 103 (18.3%) 30 (33.0%)
Lower tertiary 212 (37.7% 28 (30.8%)
Upper tertiary 203 (36.1%) 20 (22.0%)
Note. Frequencies and percentages refer to valid N of variable. Data are missing as follows: Child characteristics at 25-year follow-up: n=5 salivary cortisol
awakening AUCg and AUCi, n= 1 body mass index, n= 15 educational level, n= 28 alcohol consumption, n=9 smoking.
Table 2
Associations between maternal early pregnancy body mass index (BMI) and offspring diurnal salivary cortisol at a mean age of 25.3 years.
Maternal early
pregnancy BMI (kg/
m2)
Diurnal cortisol from awakening until bedtime (%) Diurnal cortisol from awakening to 30minutes
after awakening (%)
Diurnal cortisol from 10:30AM until bedtime (%)
% per kg/m2
increase in maternal
BMI
95% Confidence
Interval
P % per kg/m2
increase in maternal
BMI
95% Confidence
Interval
P % per kg/m2
increase in maternal
BMI
95% Confidence
Interval
P
Model 1 −1.4 (−2.6, −0.2) 0.028 −2.0 (−3.4, −0.5) 0.007 −0.6 (−2.0, 0.7) 0.36
Model 2 −1.3 (−2.6, 0.0) 0.054 −2.3 (−3.8, −0.8) 0.003 −0.5 (−2.0, 0.9) 0.46
Model 3 −1.5 (−2.9, −0.10) 0.036 −2.4 (−4.0, −0.8) 0.004 −1.1 (−2.6, 0.4) 0.15
Model 4 −1.4 (−2.7, −0.1) 0.040 −2.4 (−3.9, −0.9) 0.002 −0.8 (−2.2, 0.7) 0.29
Note. Model 1 refers to adjustment for participant’s sex/hormonal contraception, age and salivary cortisol sampling time (all time points between awakening and
bedtime for diurnal profile; awakening time, 15min and 30min thereafter for analysis from awakening to 30min after awakening; awakening time and time points
from 10:30AM to bedtime for analyses from 10:30AM to bedtime); Model 2 refers to Model 1 covariates plus participant’s body mass index in adulthood; Model 3
refers to Model 2 covariates plus participant’s gestational age at birth, birth weight SD score standardized by gestational age and sex, maternal age at delivery, parity,
maternal smoking during pregnancy, diabetic and hypertensive disorders and parental education at participant’s childhood/adulthood; Model 4 refers to Model 2
covariates plus participant’s smoking, alcohol consumption and own attained/ongoing education in adulthood.
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morning plasma cortisol or cortisol measured from fetal cord blood
(Elhassan et al., 2015; Phillips et al., 2005; Stirrat et al., 2017). These
studies have, however, examined HPA axis activity in the offspring
using study designs that differ from ours (e.g., diurnal cortisol measured
upon arrival at day care, before lunch and in the afternoon upon arrival
back to the child’s home, only once in the morning or in response to
stress) and at much younger age than our young adult sample. As our
study does not provide data on HPA axis of the offspring in childhood
and as the follow-ups of the previous studies do not yet extend to adult
age, it remains to be detected if the associations between maternal early
pregnancy BMI and offspring HPA axis change according to offspring
age. Furthermore, as the HPA axis activity is context-specific, we cannot
rule out that contextual factors, such a stress related to the sampling per
se, may have interfered with our findings. We cannot either account for
other environmental factors, such as exposure to stressful life events
that may have played a role in re-calibrating the set-point of the HPA
axis during the lifespan, as emphasized in the Adaptive Calibration
Model (Del Giudice et al., 2011) or in the Lifecycle Model of Stress
(Lupien et al., 2009). We were able to account for parental education,
offspring own adulthood education and BMI. While lower childhood
and adulthood education and higher BMI have been related with phy-
sical, social and psychological life adversities and their accumulation
over the lifespan (Adler and Newman, 2002; Dixon, 2010; Eurostat,
2010; Mackenbach et al., 2008; Stringhini et al., 2017), they can be
considered only as crude proxies. Hence, future studies are needed
using longitudinal study design to disentangle the effects on HPA axis
activity related to maturation, environmental factors and different
study designs.
A recent thorough literature review and meta-analysis on diurnal
cortisol slopes demonstrated that flatter diurnal slopes were associated
with obesity, depression, internalizing and externalizing problems,
fatigue, other mental health problems, inflammation and cancer in
general and patient populations (Adam et al., 2017). These are out-
comes that have been associated with maternal early pregnancy over-
weight/obesity (Eriksson et al., 2015; Godfrey et al., 2017; Kaseva
et al., 2018; Kong et al., 2018; Rivera et al., 2015) and/or other related
prenatal environmental adversities, such as maternal prenatal depres-
sion (Kumpulainen et al., 2018; Toffol et al., 2018.). We did not,
however, find linear or non-linear associations between maternal early
pregnancy BMI and diurnal cortisol slopes, cortisol awakening response
or mid-morning to bedtime slopes. Rather, we found linear associations
with lower average diurnal and especially lower cortisol levels at
awakening and on average in the morning. While the associations of
these cortisol measures with the physical and mental health outcomes
remain less consistent and less well-established, there is evidence that
lower salivary cortisol at awakening (Champaneri et al., 2013; Kumari
et al., 2010; Ruttle et al., 2013) and lower average morning cortisol
(Champaneri et al., 2013) are correlated with higher BMI and waist
circumference, and lower salivary cortisol at awakening and 30min
thereafter are correlated with depression (Sjögren et al., 2006) in
general populations.
The biological underpinnings of these associations remain un-
known. These include maternal HPA axis activity: maternal overweight,
obesity and severe obesity in early pregnancy are associated with
blunted maternal HPA axis activity during pregnancy (Berglund et al.,
2016; Luiza et al., 2015; Stirrat et al., 2016). Maternal overweight and
obesity are also associated with maternal hyperinsulinemia, dyslipi-
demia, impaired endothelial function, elevated blood pressure and low-
grade inflammation during pregnancy (Coussons-Read, 2013; O’Reilly
and Reynolds, 2013; Ramsay et al., 2002; Segovia et al., 2014). It is also
possible that obesity-related changes in the maternal microbiota (Nehra
et al., 2016), and differential exposure to maternal microbiota as a
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awakening                             awakening
(M=7:41AM, 
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(M=5:43PM, 
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SD=0:29 hh:mm) 
(Mean [M]=7:25AM,
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[SD]=1:17 hh:mm)
Time main eīect (from awakening unƟl bedƟme): -52.7% decrease in salivary corƟsol  per one SD increase in Ɵme, p<0.0001
Maternal early pregnancy BMI x Ɵme (from awakening unƟl bedƟme) interacƟon, p=0.52
Time main eīect (from awakening to 30 minutes aŌer awakening): 238.7% increase in salivary corƟsol per one SD increase in Ɵme, p<0.0001
Maternal early pregnancy BMI x Ɵme (from awakening to 30 minutes aŌer awakening) interacƟon, p=0.41
Time main eīect (from 10:30AM unƟl bedƟme): -47.3% decrease in salivary corƟsol  per one SD increase in Ɵme, p<0.0001
Maternal early pregnancy BMI x Ɵme (from 10:30AM unƟl bedƟme) interacƟon, p=0.45
Fig. 2. Associations between maternal body mass index (BMI) in early pregnancy and diurnal salivary cortisol profiles from awakening until bedtime in the offspring
at a mean age of 25.3 years. Salivary cortisol geometric means and their 95% confidence intervals are adjusted for time of salivary sampling, offspring sex/hormonal
contraception, and age in adulthood.
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result of caesarean section delivery (Papachatzi et al., 2016) and non-
breastfeeding (Lepe et al., 2011) which are more common in over-
weight and obesity, play a role.
Also, epigenetic and genetic factors have been suggested to be play a
role. However, a recent epigenome-wide-association-study in over 9000
mother-newborn pairs showed that maternal BMI in early pregnancy
had only a small effect on fetal global DNA methylation measured from
cord blood (Sharp et al., 2017). Only 8 sites were found to be suggestive
of direct causal intrauterine effect by maternal BMI (Sharp et al., 2017).
The study suggested that the small effect of maternal BMI at the start of
pregnancy on offspring cord blood DNA methylation “may be better
explained by genetic or lifestyle factors than a causal intrauterine me-
chanism” (Sharp et al., 2017). The role of genetic factors remains to be
elucidated: a series of genome-wide association studies have unraveled
genetic variants related to BMI (Locke et al., 2015) and plasma cortisol
(Bolton et al., 2014), but their role in shaping the HPA axis activity in
the context of early environment remains largely unknwon. Emerging
evidence also suggests that a large proportion of the offsrping DNA
methylation is accounted for by the offspring genetic factors and by
their interaction with the early enviroment (Teh et al., 2014).
Strengths of our study include a large, longitudinal sample and re-
peated measurements of salivary cortisol throughout one day from
awakening till bedtime. Of the study participants, all had at least six
and over 90% (N=610) had all seven cortisol samples available pro-
viding the possibility to reliably study diurnal salivary cortisol profiles.
The three salivary cortisol measurements upon and 15 and 30min after
awakening were highly intercorrelated (intraclass correlations>0.76),
providing support for the consistency of the morning cortisol assess-
ment. We were also able to account for a wide number of confounders,
including the offspring’s own young adulthood BMI, and conducted
sensitivity analyses to increase internal validity (Adam and Kumari,
2009). We cannot, however, entirely rule out the possibility of residual
confounding.
There are limitations to our study. Cortisol sampling was performed
on a single day. Cortisol levels may differ substantially within-in-
dividuals between sampling days (Clow et al., 2010). However, de-
manding procedures that include several sampling days may decrease
compliance and participation rate (Adam and Kumari, 2009) and in
large samples, like ours, increase costs. As participants collected saliva
samples in their daily environment, cortisol sampling times were self-
reported. While 89.9% of the participants reported all sampling times,
10.1% had a missing recording in at least one of the sampling times
(393 of 4528 sampling times were imputed). Some studies suggest that
non-compliance may especially influence cortisol awakening response
and diurnal slope (Broderick et al., 2004; Kudielka et al., 2003). Yet, the
inclusion of time-discordant samples have not been shown to result in
differences in cortisol levels or blunted diurnal slopes in a study in
which signal-contingent time-sampling protocol was used (Jacobs et al.,
2005). In our study, exclusion of salivary cortisol values, for which we
imputed the missing sampling time, changed the results only a little.
Nevertheless, the inaccuracy related to self-reported sampling times
should be borne in mind when interpreting the study findings.
A further study limitation relates to the birth year of our cohort.
Over two decades ago when our cohort was born, the prevalence of
overweight (11.6% in our cohort) and obesity (2.3% in our cohort) in
pregnant Finnish women was much lower than the prevalence in
pregnant Finnish women (overweight 20.7%; obese 11.3%) (Kong
et al., 2018) and in the world in more recent cohorts (Branum et al.,
2016; Deputy et al., 2018; Devlieger et al., 2016; Euro-Peristat, 2013).
This clearly limits statistical power and generalizability to cohorts born
more recently, but remains an unavoidable limitation when studying
today’s adult populations. Also lack of data about exposure to ecolo-
gical stress/positive environment across the offspring lifespan, in ad-
dition to lack of data about their somatic health, is a study limitation.
Loss to follow up in longitudinal studies is also inevitable. The
follow-up attrition was related to maternal and child perinatalTa
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characteristics. Hence, our findings may not be generalized to popula-
tions that vary in characteristics from our study sample.
5. Conclusions
To conclude, our study showed that young adult offspring of mo-
thers with higher BMI in early pregnancy have lower average levels of
salivary cortisol during the day, especially in the morning. Whether
these findings reflect prenatal programming of the offspring HPA-axis
activity warrants further investigation.
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